161 related articles for article (PubMed ID: 2198750)
21. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
[TBL] [Abstract][Full Text] [Related]
22. Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis.
Dadzie KY; Bird AC; Awadzi K; Schulz-Key H; Gilles HM; Aziz MA
Br J Ophthalmol; 1987 Feb; 71(2):78-85. PubMed ID: 3548811
[TBL] [Abstract][Full Text] [Related]
23. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
Mbah GE; Ayiseh RB; Cho-Ngwa F
BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
[TBL] [Abstract][Full Text] [Related]
24. [Control of onchocerciasis vectors in West Africa: description of the logistics adapted for a large-scale public health program].
Hougard JM; Poudiougo P; Zerbo G; Meyer R; Guillet P; Agoua H; Seketeli A; Akpoboua A; Sowah S; Samba EM
Sante; 1994; 4(6):389-98. PubMed ID: 7850190
[TBL] [Abstract][Full Text] [Related]
25. Onchocerciasis in West Africa after 2002: a challenge to take up.
Hougard JM; Yameogo L; Philippon B
Parasite; 2002 Jun; 9(2):105-11. PubMed ID: 12116855
[TBL] [Abstract][Full Text] [Related]
26. Onchocerciasis control in Ghana (1974-2016).
Biritwum NK; de Souza DK; Asiedu O; Marfo B; Amazigo UV; Gyapong JO
Parasit Vectors; 2021 Jan; 14(1):3. PubMed ID: 33388081
[TBL] [Abstract][Full Text] [Related]
27. Ivermectin--clinical trials and treatment schedules in onchocerciasis.
Brown KR; Neu DC
Acta Leiden; 1990; 59(1-2):169-75. PubMed ID: 2198749
[TBL] [Abstract][Full Text] [Related]
28. Effect of ivermectin on the vertical distribution of Onchocerca volvulus microfilariae in the skin.
Jürgens S; Schulz-Key H
Trop Med Parasitol; 1990 Jun; 41(2):165-8. PubMed ID: 2382096
[TBL] [Abstract][Full Text] [Related]
29. Control of onchocerciasis.
Boatin BA; Richards FO
Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
[TBL] [Abstract][Full Text] [Related]
30. Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
Abiose A; Jones BR; Cousens SN; Murdoch I; Cassels-Brown A; Babalola OE; Alexander ND; Nuhu I; Evans J; Ibrahim UF
Lancet; 1993 Jan; 341(8838):130-4. PubMed ID: 8093742
[TBL] [Abstract][Full Text] [Related]
31. Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
Mössinger J; Schulz-Key H; Dietz K
Trop Med Parasitol; 1988 Dec; 39(4):313-6. PubMed ID: 3067322
[TBL] [Abstract][Full Text] [Related]
32. Progress towards the elimination of onchocerciasis as a public-health problem in Uganda: opportunities, challenges and the way forward.
Ndyomugyenyi R; Lakwo T; Habomugisha P; Male B
Ann Trop Med Parasitol; 2007 Jun; 101(4):323-33. PubMed ID: 17524247
[TBL] [Abstract][Full Text] [Related]
33. Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in West Africa.
Plaisier AP; Alley ES; Boatin BA; Van Oortmarssen GJ; Remme H; De Vlas SJ; Bonneux L; Habbema JD
J Infect Dis; 1995 Jul; 172(1):204-10. PubMed ID: 7797912
[TBL] [Abstract][Full Text] [Related]
34. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
[TBL] [Abstract][Full Text] [Related]
35. Ivermectin treatment of ocular onchocerciasis.
Taylor HR
Acta Leiden; 1990; 59(1-2):201-6. PubMed ID: 2198751
[TBL] [Abstract][Full Text] [Related]
36. Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holo-endemic onchocerciasis focus.
Dadzie KY; Remme J; De Sole G
Trans R Soc Trop Med Hyg; 1991; 85(2):267-71. PubMed ID: 1887490
[TBL] [Abstract][Full Text] [Related]
37. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda.
Fischer P; Kipp W; Bamuhiga J; Binta-Kahwa J; Kiefer A; Büttner DW
Trop Med Parasitol; 1993 Dec; 44(4):311-21. PubMed ID: 8134773
[TBL] [Abstract][Full Text] [Related]
38. Does onchocerciasis transmission take place in hypoendemic areas? a study from the North Region of Cameroon.
Katabarwa MN; Eyamba A; Chouaibou M; Enyong P; Kuété T; Yaya S; Yougouda A; Baldiagaï J; Madi K; Andze GO; Richards F
Trop Med Int Health; 2010 May; 15(5):645-52. PubMed ID: 20345553
[TBL] [Abstract][Full Text] [Related]
39. [Human onchocerciasis in Africa].
Boussinesq M
Med Trop (Mars); 1997; 57(4):389-400. PubMed ID: 9612783
[TBL] [Abstract][Full Text] [Related]
40. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
